REFERENCE
Högl B, Poewe W, Garcia-Borreguero D, Ferini-Strambi L, Trenkwalder C.26-weeks of pramipexole on quality of life in restless legs syndrome. 13th International Congress of Parkinson's Disease and Movement Disorders: 440 abstr. Tu-315, 7 Jun 2009. Available from: URL: http://www.movementdisorders.org
Rights and permissions
About this article
Cite this article
Pramipexole makes a difference to the QOL of patients with restless leg syndrome. Pharmacoecon. Outcomes News 581, 10 (2009). https://doi.org/10.2165/00151234-200905810-00031
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905810-00031